BioLife Solutions, Inc.
BioLife Solutions, Inc. (BLFS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
blfs · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$34.00
Consensus
$34.00
+26.1% upside
Low
$34.00
Median: $34 · Last Close: $26.97
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.32 | ↑ 5.00% |
1-day model range: $28.15–$28.49. Peak: $28.49 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $29 | +6.4% |
| 2028 | $30 | +10.1% |
| 2029 | $30 | +12.2% |
| 2030 | $31 | +13.4% |
| 2031 | — | +14.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BLFS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-08 | Northland Capital Markets | Maintains | Outperform→Outperform |
| 2024-12-19 | Benchmark | Maintains | Buy→Buy |
| 2024-12-13 | Keybanc | Maintains | Overweight→Overweight |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-13 | TD Cowen | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on BioLife Solutions, Inc. (BLFS) stock. Of the recent 51 rating actions, 3 were upgrades and 3 were downgrades. 17 analysts currently cover BLFS.
Analyst Recommendation Trends
BLFS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$114M
↓ 31.2% YoY
Revenue Next Year
$134M
↑ 17.9% YoY
EPS This Year
$0.14
EPS Next Year
$0.32
↑ 127.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BLFS EPS of $0.14 for the current fiscal year, based on estimates from 3 analysts. The BLFS revenue forecast is $114M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BLFS stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BLFS price target is $34.00 (+26.1% upside), with an analyst consensus of Buy.
The BLFS short-term stock prediction for tomorrow is $28.32 (+5.00%). The BLFS stock price prediction for 2027 estimates an average of $29. The BLFS stock prediction for 2030 projects a range of $29–$33.
BioLife Solutions, Inc. trades on NASDAQ under the ticker BLFS. The BLFS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BLFS forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month BLFS price target is $34.00, with a high forecast of $34.00 and a low of $34.00. The median price target is shown in the chart above when available. This implies +26.1% potential upside from the current price of $26.97.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.